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Letters to the Editor1094ompared to primary PCI in this time frame (3). Importantly, in
his registry, only 14.6% of patients were able to receive primary
CI within 2 h of symptom onset, whereas 50.5% of patients were
ble to receive thrombolysis.
Irrespective of the method chosen, the aim of reperfusion is to
alvage myocardium and improve outcomes. A wealth of data
ndicates that reperfusion within 2 h of symptom onset results in
arkedly better outcomes than reperfusion at later intervals. Even
ith effective public education campaigns, it is likely that only a
mall minority of patients can ever receive primary PCI within 2 h
f the onset of symptoms, whereas a substantial proportion of
atients can receive PHT and achieve reperfusion within this time
rame. Rather than primary PCI for patients presenting early after
he onset of symptoms, ambulance-administered thrombolysis
ollowed by transport to a PCI capable hospital is the protocol that
hould be promoted.
Richard W. Harper, MBBS
Monash Medical Centre
46 Clayton Road
layton 3168
ictoria, Australia
-mail: richard.harper@med.monash.edu.au
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eply
ith interest we read the comments of Dr. Lozano and colleagues
nd Dr. Harper on the issue of reperfusion therapy for “pre-
ospitally” diagnosed ST-segment elevation myocardial infarction
atients presenting early after symptom onset. Although Dr.
arper suggests fibrinolysis with an early invasive strategy in all
re-hospital patients, Dr. Lozano and colleagues suggest this
trategy under “certain circumstances.” Our registry data show that
ith our strategy of pre-hospital diagnosis, catheter laboratory
otification from the ambulance, and direct transportation to an
ntervention center with optimal in-hospital logistics, primary
ngioplasty can be performed within 90 min of diagnosis in more
han 80% of patients. We acknowledge that pre-hospital and
n-hospital infrastructure varies per country and region, which
ight affect the preferred reperfusion therapy.
The current guidelines state that primary angioplasty is thenequivocally preferred reperfusion strategy, if it can be performedithin 90 min of presentation by an experienced team of personnel
1). The guidelines are based on the currently available evidence,
ncluding the CAPTIM (Comparison of Primary Angioplasty and
rehospital Fibrinolysis in Acute Myocardial Infarction Trial)
esults, and they do not make an exception for pre-hospital (or
arly) presenting patients. Dr. Harper’s statement that an early
re-hospital fibrinolytic strategy is superior to primary angioplasty
acks sufficient scientific evidence and therefore is not supported by
urrent guidelines. The remark that our results would have been
etter if a pre-hospital fibrinolytic strategy would have been used
nstead of primary angioplasty is presumptuous.
We agree with Dr. Lozano and colleagues that pre-hospital
brinolysis with a routine early invasive strategy is the preferred
eperfusion strategy under certain circumstances—namely if high-
uality primary angioplasty performed in a timely fashion is not
vailable. Our registry was initiated to monitor treatment delays in
rimary angioplasty. Before the initiation of primary angioplasty,
re-hospital fibrinolysis with a liberal rescue strategy has been
uccessfully used for more than 1 decade, with two-thirds of
atients being treated within 2 h of symptom onset. Our primary
ngioplasty data demonstrate that most patients are treated within
he time window of the guideline. Moreover, we show that
uideline adherence can be substantially improved if all patients are
eferred directly to an intervention center instead of through a
onintervention center.
We concur with both authors that the impact of (early)
re-hospital fibrinolysis with an early invasive strategy in patients
t low risk of bleeding might be underestimated, and this strategy
eserves further study. To date, the CAPTIM study is the only
vailable randomized trial in the pre-hospital setting comparing
oth reperfusion strategies in the optimal setting. The suggested
uperiority of early fibrinolysis stems from a subgroup analysis of a
rematurely discontinued, overall neutral trial, and these results
hould be interpreted with caution. The currently enrolling
TREAM (Strategic Reperfusion Early After Myocardial Infarc-
ion) trial compares both reperfusion strategies in patients present-
ng within 3 h of symptom onset, and results are eagerly awaited.
t least until then, timely high-quality primary angioplasty re-
ains the treatment of preference.
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eply
e thank Dr. Lozano and colleagues for their comments concern-
ng our editorial and the issue of the role and benefit of pre-
ospital fibrinolytic therapy. We agree that in certain circum-
tances, when there is a delay to reperfusion with primary
ercutaneous coronary intervention (PCI) in patients who are
ow-risk and in whom fibrinolytic therapy is not contraindicated,
re-hospital or in-hospital fibrinolysis with a routine pharmaco-
nvasive strategy may be preferred, as noted in the most recent
ocused update of the American College of Cardiology (ACC) and
merican Heart Association (AHA) ST-segment elevation myo-
ardial infarction (STEMI) guidelines (1).
In fact, both the European Society of Cardiology STEMI
uidelines (2) and the ACC/AHA STEMI guidelines (3) address
ecommendations (class IIa) for pre-hospital fibrinolytic therapy.
owever, in the U.S., most emergency medical services systems do
ot have teams trained in the administration of pre-hospital
brinolysis or physicians present in emergency vehicles.
Moreover, the ACC/AHA STEMI guidelines have now
ocused—on the basis of studies similar to the one by Dieker et al.
4)—on the development of systems of care (as noted in the
ollowing text) to increase the number of STEMI patients with
imely access to primary PCI, the (evidence-based) preferred
eperfusion strategy.
“Each community should develop a STEMI system of care that
ollows standards at least as stringent as those developed for the
HA’s, national initiative, Mission: Lifeline, to include the
ollowing: ongoing multidisciplinary team meetings that includemergency medical services, non–PCI-capable hospitals/STEMI
eferral centers, and PCI-capable hospitals/STEMI receiving cen-
ers to evaluate outcomes and quality improvement data; a process
or pre-hospital identification and activation; destination protocols
or STEMI receiving centers; transfer protocols for patients who
rrive at STEMI referral centers who are primary PCI candidates,
re ineligible for fibrinolytic drugs, and/or are in cardiogenic
hock” (Class I, Level of Evidence: C) (1).
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